logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12011441 B1

PDFFull Text
Date of Patent:
Jun. 18, 2024

Filed:

Sep. 14, 2018

Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Applicant:

Boehringer Ingelheim Vetmedica Gmbh, Ingelheim am Rhein, DE;

Inventors:

Christoph Matthias Schummer, Weilrod, DE;

Olaf Joens, Ober-Hilbersheim, DE;

Assignee:
Attorney:
Primary Examiner:

Irina Neagu

Int. Cl.
CPC ...
A61K 31/501 (2006.01); A61K 31/50 (2006.01); A61K 31/55 (2006.01); A61K 31/635 (2006.01); A61P 9/04 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/501 (2013.01); A61K 31/50 (2013.01); A61K 31/55 (2013.01); A61K 31/635 (2013.01); A61P 9/04 (2018.01); A61K 9/20 (2013.01); A61K 2300/00 (2013.01);
Abstract

Pimobendan is used for reducing the heart size and/or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), and/or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), wherein the patient is preferably a mammal, more preferably a human, a dog, a cat or a horse, and most preferably a dog.

Find Patent Forward Citations

Schummer, Christoph. (2024). Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease (U.S. Patent No. 12011441). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12011441

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…